series-c-plus
Stage
2016
Founded
2
Investors
About
CytoReason develops an AI-powered platform that builds computational disease models to accelerate drug discovery and development for pharmaceutical companies.
Explore CytoReason's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.